Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1985 Nov;62(2):397–404.

Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positive cells.

A N Akbar, P J Giardina, M W Hilgartner, R W Grady
PMCID: PMC1577434  PMID: 3878749

Abstract

Multiply transfused patients with beta-thalassaemia major have elevated serum immunoglobulin levels and a transfusion-related increase in (T8+) T-suppressor cells. We report here that these patients also have a significantly increased (P less than 0.001) proportion of B-cells that contain cytoplasmic immunoglobulin when visualized immediately upon isolation. On the other hand, the same cell populations do not exhibit an increase in the proportion of immunoglobulin-secreting cells as measured by a reverse haemolytic plaque assay. These results, together with those of ongoing studies, suggest that the cells containing the cytoplasmic immunoglobulin are likely to be terminally differentiated B-cells which persist in the circulation. While the reason for this phenomenon is not yet known, we have found that the increase in these cells is transfusion-related.

Full text

PDF
397

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akbar A. N., Jones D. B., Wright D. H. Spontaneous and Concanavalin A-induced suppressor activity in control and Hodgkin's disease patients. Br J Cancer. 1984 Mar;49(3):349–356. doi: 10.1038/bjc.1984.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baines M. G., Lafleur F. L., Holbein B. E. Involvement of transferrin and transferrin receptors in human natural killer effector:target interaction. Immunol Lett. 1983;7(1):51–55. doi: 10.1016/0165-2478(83)90055-x. [DOI] [PubMed] [Google Scholar]
  3. Brieva J. A., Stevens R. H. Involvement of the transferrin receptor in the production and NK-induced suppression of human antibody synthesis. J Immunol. 1984 Sep;133(3):1288–1292. [PubMed] [Google Scholar]
  4. Brieva J. A., Targan S., Stevens R. H. NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells. J Immunol. 1984 Feb;132(2):611–615. [PubMed] [Google Scholar]
  5. Constantoulakis M., Trichopoulos D., Avgoustaki O., Economidou J. Serum immunoglobulin concentrations before and after splenectomy in patients with homozygous beta-thalassaemia. J Clin Pathol. 1978 Jun;31(6):546–550. doi: 10.1136/jcp.31.6.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gascón P., Zoumbos N. C., Young N. S. Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med. 1984 Feb;100(2):173–177. doi: 10.7326/0003-4819-100-2-173. [DOI] [PubMed] [Google Scholar]
  7. Grady R. W., Akbar A. N., Giardina P. J., Hilgartner M. W., de Sousa M. Disproportionate lymphoid cell subsets in thalassaemia major: the relative contributions of transfusion and splenectomy. Br J Haematol. 1985 Apr;59(4):713–724. doi: 10.1111/j.1365-2141.1985.tb07367.x. [DOI] [PubMed] [Google Scholar]
  8. Graziano J. H., Piomelli S., Hilgartner M., Giardina P., Karpatkin M., Andrew M., LoIacono N., Seaman C. Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance. J Pediatr. 1981 Nov;99(5):695–699. doi: 10.1016/s0022-3476(81)80386-1. [DOI] [PubMed] [Google Scholar]
  9. Hirano T., Teranishi T., Onoue K. Human helper T cell factor(s). III. Characterization of B cell differentiation factor I (BCDF I). J Immunol. 1984 Jan;132(1):229–234. [PubMed] [Google Scholar]
  10. Kallenberg C. G., Limburg P. C., Van Slochteren C., Van der Woude F. J., The T. H. B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. Clin Exp Immunol. 1983 Aug;53(2):371–383. [PMC free article] [PubMed] [Google Scholar]
  11. Kapadia A., de Sousa M., Markenson A. L., Miller D. R., Good R. A., Gupta S. Lymphoid cell sets and serum immunoglobulins in patients with thalassaemia intermedia: relationship to serum iron and splenectomy. Br J Haematol. 1980 Jul;45(3):405–416. doi: 10.1111/j.1365-2141.1980.tb07161.x. [DOI] [PubMed] [Google Scholar]
  12. Kaplan J., Sarnaik S., Gitlin J., Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood. 1984 Jul;64(1):308–310. [PubMed] [Google Scholar]
  13. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  14. Modell B. Total management of thalassaemia major. Arch Dis Child. 1977 Jun;52(6):489–500. doi: 10.1136/adc.52.6.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Muraguchi A., Kehrl J. H., Butler J. L., Fauci A. S. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig. J Immunol. 1984 Jan;132(1):176–180. [PubMed] [Google Scholar]
  16. Neckers L. M., Cossman J. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3494–3498. doi: 10.1073/pnas.80.11.3494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pardo I., Levinson A. I. Circulating immunoglobulin-secreting cells in rheumatoid arthritis. Clin Immunol Immunopathol. 1983 Oct;29(1):29–34. doi: 10.1016/0090-1229(83)90004-1. [DOI] [PubMed] [Google Scholar]
  18. Tovo P. A., Miniero R., Barbera C., Sacchetti L., Saitta M. Serum immunoglobulins in homozygous beta-thalassemia. Acta Haematol. 1981;65(1):21–25. doi: 10.1159/000207144. [DOI] [PubMed] [Google Scholar]
  19. Wasi C., Wasi P., Thongcharoen P. Serum-immunoglobulin levels in thalassaemia and the effects of splenectomy. Lancet. 1971 Jul 31;2(7718):237–239. doi: 10.1016/s0140-6736(71)92573-6. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES